{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-001895","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2023-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.635744+00:00","generated_at":"2026-06-20T18:55:38.725494+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CEO John Jacobs resigns; CMO Jeffrey Dayno named Interim CEO; Jeff Aronin becomes Executive Chairman","bullets":["CEO John C. Jacobs resigns effective Jan 20, 2023 to pursue another opportunity; no disagreement with Company.","Jeffrey M. Dayno, current CMO, appointed Interim CEO effective Jan 6, 2023; will remain CMO.","Founder and Board Chairman Jeffrey S. Aronin appointed Executive Chairman to provide oversight during transition.","Board expresses confidence in underlying business and strategic execution."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-001895","json":"https://secwatch.observer/filing/0001104659-23-001895.json","markdown":"https://secwatch.observer/filing/0001104659-23-001895.md","text":"https://secwatch.observer/filing/0001104659-23-001895.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/0001104659-23-001895-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/tm232529d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T18:55:38.725494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e5c41d515","claim":"Jeffrey M. Dayno was appointed as Interim Chief Executive Officer at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"On January 6, 2023, the Board appointed Dr. Jeffrey M. Dayno, the Company’s current Chief Medical Officer, as the Company’s Interim Chief Executive Officer, effective January 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/0001104659-23-001895-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"8cbca0d354","claim":"John C. Jacobs resigned as President and Chief Executive Officer at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"On January 6, 2023, Harmony Biosciences Holdings, Inc. (the “Company”) announced that John C. Jacobs is resigning as President and Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/0001104659-23-001895-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b9ebf1eb5c","claim":"Jeffrey S. Aronin was appointed as Executive Chairman at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"On January 6, 2023, in connection with Mr. Jacobs’ resignation from the Board and to provide additional support and oversight during this transition period, the Board appointed Jeffrey S. Aronin, currently Chairman of the Board, as the Company’s Executive Chairman, effective January 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/0001104659-23-001895-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}